VC funding 2013: Playing the game but fewer high rollers
This article was originally published in Clinica
Executive Summary
2013 has not been a bad year for medtech venture fundraising. The first half of 2013 showed a robust level of activity, with monthly deal volume on an upward trajectory between January and June, save for a dip in May (Figure 1). Then the second half kicked off with an all-year high as July recorded 35 transactions. However, activity has quickly cooled off since then, with the following months (aside from a surge in October) struggling to see their deal volume go beyond 20 per month.